Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 545-551

  Takaguri, Akira ^a   Shirai, Heigoro ^a   Kimura, Keita ^a   Hinoki, Akinari ^a   Eguchi, Kunie ^a   Carlile Klusacek, MaryEllen ^a   Yang, Baohua ^a   Rizzo, Victor ^a   Eguchi, Satoru ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Caveolin; Hypertrophy; Metalloprotease; Migration; Vascular smooth muscle cells

Indexed keywords

ADAM17 PROTEIN; ANGIOTENSIN II; CALCIUM ION; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; FILIPIN; METALLOPROTEINASE; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; SUCROSE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL FRACTIONATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HYPERTROPHY; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE; VIRUS CELL INTERACTION;

ADAM PROTEINS; ANGIOTENSIN II; ANIMALS; BETA-CYCLODEXTRINS; CALCIUM; CAVEOLIN 1; CELL MOVEMENT; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FILIPIN; GENE TRANSFER TECHNIQUES; HYPERTROPHY; MEMBRANE MICRODOMAINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VENTRICULAR REMODELING;

ADENOVIRIDAE;

EID: 79551586247     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.12.009     Document Type: Article

References (40)

1. Daugherty A., Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med 2004, 14:117-120.
2. Crowley S.D., Gurley S.B., Coffman T.M. AT(1) receptors and control of blood pressure: the kidney and more. Trends Cardiovasc Med 2007, 17:30-34.
3. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000, 52:639-672.
4. Ohtsu H., Suzuki H., Nakashima H., Dhobale S., Frank G.D., Motley E.D., et al. Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells. Hypertension 2006, 48:534-540.
5. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007, 292:C82-C97.
6. Ohtsu H., Dempsey P.J., Frank G.D., Brailoiu E., Higuchi S., Suzuki H., et al. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. Arterioscler Thromb Vasc Biol 2006, 26:e133-e137.
7. Higuchi S., Ohtsu H., Suzuki H., Shirai H., Frank G.D., Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 2007, 112:417-428.
8. Ohtsu H., Dempsey P.J., Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 2006 Jul, 291(1):C1-C10.
9. Smith N.J., Luttrell L.M. Signal switching, crosstalk, and arrestin scaffolds: novel G protein-coupled receptor signaling in cardiovascular disease. Hypertension 2006, 48:173-179.
10. Gratton J.P., Bernatchez P., Sessa W.C. Caveolae and caveolins in the cardiovascular system. Circ Res 2004, 94:1408-1417.
11. Callera G.E., Montezano A.C., Yogi A., Tostes R.C., Touyz R.M. Vascular signaling through cholesterol-rich domains: implications in hypertension. Curr Opin Nephrol Hypertens 2007, 16:90-104.
12. Ushio-Fukai M., Alexander R.W. Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension 2006, 48:797-803.
13. Ushio-Fukai M., Hilenski L., Santanam N., Becker P.L., Ma Y., Griendling K.K., et al. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 2001, 276:48269-48275.
14. Ushio-Fukai M., Zuo L., Ikeda S., Tojo T., Patrushev N.A., Alexander R.W. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Circ Res 2005, 97:829-836.
15. von Tresckow B., Kallen K.J., von Strandmann E.P., Borchmann P., Lange H., Engert A., et al. Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. J Immunol 2004, 172:4324-4331.
16. Thiel K.W., Carpenter G. ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains. Biochem Biophys Res Commun 2006, 350:629-633.
17. Wakatsuki S., Kurisaki T., Sehara-Fujisawa A. Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin beta/ADAM19. J Neurochem 2004, 89:119-123.
18. Zimina E.P., Bruckner-Tuderman L., Franzke C.W. Shedding of collagen XVII ectodomain depends on plasma membrane microenvironment. J Biol Chem 2005, 280:34019-34024.
19. Eguchi S., Matsumoto T., Motley E.D., Utsunomiya H., Inagami T. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996, 271:14169-14175.
20. Sowa G., Pypaert M., Sessa W.C. Distinction between signaling mechanisms lipid rafts vs caveolae. Proc Natl Acad Sci USA 2001, 98:14072-14077.
21. Tokumaru S., Higashiyama S., Endo T., Nakagawa T., Miyagawa J.I., Yamamori K., et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol 2000, 151:209-220.
22. Eguchi S., Iwasaki H., Ueno H., Frank G.D., Motley E.D., Eguchi K., et al. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 1999, 274:36843-36851.
23. Eguchi S., Numaguchi K., Iwasaki H., Matsumoto T., Yamakawa T., Utsunomiya H., et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 1998, 273:8890-8896.
24. Suzuki H., Kimura K., Shirai H., Eguchi K., Higuchi S., Hinoki A., et al. Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration. Arterioscler Thromb Vasc Biol 2009, 29:217-224.
25. Suzuki H., Eguchi K., Ohtsu H., Higuchi S., Dhobale S., Frank G.D., et al. Activation of endothelial nitric oxide synthase by the angiotensin II Type-1 receptor. Endocrinology 2006, 147:5914-5920.
26. Nakashima H., Frank G.D., Shirai H., Hinoki A., Higuchi S., Ohtsu H., et al. Novel role of protein kinase C delta Tyr311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II. Hypertension 2008, 51:232-238.
27. Ohtsu H., Higuchi S., Shirai H., Eguchi K., Suzuki H., Hinoki A., et al. Central role of Gq in the hypertrophic signal transduction of angiotensin II in vascular smooth muscle cells. Endocrinology 2008, 149:3569-3575.
28. Geisterfer A.A., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988, 62:749-756.
29. Mifune M., Ohtsu H., Suzuki H., Nakashima H., Brailoiu E., Dun N.J., et al. G protein coupling and second messenger generation are indispensable for a metalloprotease-dependent HB-EGF shedding through angiotensin II type-1 receptor. J Biol Chem 2005, 280:26592-26599.
30. Carlile Klusacek M., Rizzo V. Endothelial cytoskeletal reorganization response to protease activated receptor-1 (PAR1) stimulation is mediated by membrane rafts but not caveolae. Am J Physiol Heart Circ Physiol 2007, 293:H366-H375.
31. Ingueneau C., Huynh-Do U., Thiers J.C., Negre-Salvayre A., Salvayre R., Vindis C. Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis. Biochem Biophys Res Commun 2008, 369:889-893.
32. Eguchi S., Dempsey P.J., Frank G.D., Motley E.D., Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 2001, 276:7957-7962.
33. Konishi A., Berk B.C. Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells. J Biol Chem 2003, 278:35049-35056.
34. Ashino T., Sudhahar V., Urao N., Oshikawa J., Chen G.F., Wang H., et al. Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration. Circ Res 2010, 107:787-799.
35. Olivares-Reyes J.A., Shah B.H., Hernandez-Aranda J., Garcia-Caballero A., Farshori M.P., Garcia-Sainz J.A., et al. Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors. Mol Pharmacol 2005, 68:356-364.
36. Peterson T.E., Guicciardi M.E., Gulati R., Kleppe L.S., Mueske C.S., Mookadam M., et al. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 2003, 23:1521-1527.
37. Hassan G.S., Jasmin J.F., Schubert W., Frank P.G., Lisanti M.P. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 2004, 43:8312-8321.
38. Hassan G.S., Williams T.M., Frank P.G., Lisanti M.P. Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. Am J Physiol Heart Circ Physiol 2006, 290:H2393-H2401.
39. Zuo L., Ushio-Fukai M., Ikeda S., Hilenski L., Patrushev N., Alexander R.W. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 2005, 25:1824-1830.
40. Seals D.F., Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003, 17:7-30.